What did BB say that isn’t true? He’s not down ramping or starting an argument. He’s speaking the truth as a shareholder.
Ex1 has been a massive disappointment in terms of shareprice since the second last capital raise. They over promised and have under delivered. If you look at the shareprice chart and think it hasn’t been a disappointment then we’re on different planets.
They need to do what they said they were close to a long time ago, land a deal.
Ann: Exopharm Gains US Patent for LEAP Technology, page-4
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
